Project Code: 10464929
Faculty: Liggins Institute
Department: Liggins Institute
Main Supervisor: Dr Katie Groom (kgro017)
Application open date: 30 Jun 2020
Application deadline: 31 Oct 2020
Enrolment information: NZ Citizens, NZ Permanent Residents
Birth by planned caesarean section compared to planned vaginal birth increases the risk of neonatal respiratory morbidity and the need for babies to be admitted to a neonatal unit.
Use of antenatal corticosteroids in women undergoing planned caesarean section at term or late preterm is supported by findings of improved neonatal respiratory morbidity in a limited number of randomised trials but may increase the risk of neonatal hypoglycaemia.
We are undertaking a large Health Research Council funded multicentre placebo-controlled trial to assess both the neonatal benefit and potential harm of maternal corticosteroid use prior to planned caesarean section at ≥35+0 to 39+6 weeks.
We aim to explore the effect of cost-effectiveness of this intervention as well as explore its potential health benefits.
Must meet the requirements for entry to a PhD programme.
To use data from the C*STEROID Trial to examine the cost-effectiveness of the use antenatal corticosteroids prior to planned caesarean section at term and late preterm gestations.
More about the C*STEROID Trial.